ONE-WAYDated event · through FY2026
Development, approval, and launch of an in vitro diagnostic for Entamoeba histolytica infection
An individual product project involving the development, application for and acquisition of marketing approval, health insurance coverage, and launch of an in vitro diagnostic to determine the presence of Entamoeba histolytica infection through blood testing.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2021 →Last written FY2026
Directionhelps1 helps · 0 hurts · 0 flat